SMITH JASON DREW (General Counsel) sold 3.4% of their position (1.52K shares) of UROGEN PHARMA LTD. on the open market
Open‑market sale worth $29.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/9/2025ACC: 0001437749-25-028705
Officer· General Counsel
Since Aug 2020
-1.52K
Net shares
Net seller
$29.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
3.33K acquired · 4.85K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
+3.33K
Price / share
—
Trade value
—
% of position
8.0%
9/7/2025
41.49K→44.83K
Ordinary Shares
Direct
Shares
−1.52K
Price / share
$19.11
Trade value
$29.05K
% of position
3.4%
9/8/2025
44.83K→43.30K
Total
Net shares
+1.81K
Net value
-$29.05K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 9/7/2025 | M · Option Exercise | +3.33K | — | — | 8.0% | 41.49K | 44.83K |
| Ordinary Shares Direct | 9/8/2025 | S · Sale | −1.52K | $19.11 | $29.05K | 3.4% | 44.83K | 43.30K |
| Total | +1.81K | -$29.05K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Ordinary Shares
3.33K shares
Shares
−3.33K
Strike price
Held after
3.33K
Exercisable
—
9/7/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Ordinary Shares3.33K shares | 9/7/2025 | M · Option Exercise | −3.33K | — | 3.33K |